-
1
-
-
32244437347
-
Ophthalmological events in patients receiving risedronate: Summary of information gained through follow-up in a prescription-event monitoring study in England
-
DOI 10.2165/00002018-200629020-00005
-
Barrera BA, Wilton L, Harris S, Shakir SA (2006) Ophthalmological events in patients receiving risedronate: summary of information gained through follow-up in a prescription-event monitoring study in England. Drug Saf 29(2):151-160 (Pubitemid 43213888)
-
(2006)
Drug Safety
, vol.29
, Issue.2
, pp. 151-160
-
-
Aurich-Barrera, B.1
Wilton, L.2
Harris, S.3
Shakir, S.A.W.4
-
2
-
-
0027339190
-
Bisphosphonates and iritis
-
Siris ES (1993) Bisphosphonates and iritis. Lancet 341(8842):436-437
-
(1993)
Lancet
, vol.341
, Issue.8842
, pp. 436-437
-
-
Siris, E.S.1
-
3
-
-
47749144029
-
Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort
-
French DD, Margo CE (2008) Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort. Retina 28(6):889-893
-
(2008)
Retina
, vol.28
, Issue.6
, pp. 889-893
-
-
French, D.D.1
Margo, C.E.2
-
4
-
-
10744232515
-
Fever after zoledronic acid administration is due to increase in TNF-α and IL-6
-
DOI 10.1089/107999003322558782
-
Dicuonzo G, Vincenzi B, Santini D et al (2003) Fever after zoledronic acid administration is due to increase in TNF- and IL-6. J Interferon Cytokine Res 23:649-654 (Pubitemid 37452905)
-
(2003)
Journal of Interferon and Cytokine Research
, vol.23
, Issue.11
, pp. 649-654
-
-
Dicuonzo, G.1
Vincenzi, B.2
Santini, D.3
Avvisati, G.4
Rocci, L.5
Battistoni, F.6
Gavasci, M.7
Borzomati, D.8
Coppola, R.9
Tonini, G.10
-
5
-
-
57349164809
-
Unilateral anterior uveitis complicating zoledronic acid therapy in prostate cancer
-
Banal F, Briot K, Ayoub G, Dougados M, Roux C (2008) Unilateral anterior uveitis complicating zoledronic acid therapy in prostate cancer. J Rheumatol 35(12):2458-2459
-
(2008)
J Rheumatol
, vol.35
, Issue.12
, pp. 2458-2459
-
-
Banal, F.1
Briot, K.2
Ayoub, G.3
Dougados, M.4
Roux, C.5
-
6
-
-
0037181829
-
Episcleritis secondary to risedronate
-
Review. In Spanish
-
Viñas G, Olivé A, Holgado S, Crsosta J (2002) Episcleritis secondary to risedronate. Med Clin (Barc) 118(15):598-599, Review. In Spanish
-
(2002)
Med Clin (Barc)
, vol.118
, Issue.15
, pp. 598-599
-
-
Viñas, G.1
Olivé, A.2
Holgado, S.3
Crsosta, J.4
-
7
-
-
0019799332
-
A method for estimating the probability of adverse drug reactions
-
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30(2):239-245 (Pubitemid 12149145)
-
(1981)
Clinical Pharmacology and Therapeutics
, vol.30
, Issue.2
, pp. 239-245
-
-
Naranjo, C.A.1
Busto, U.2
Sellers, E.M.3
-
8
-
-
29044443123
-
Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England
-
DOI 10.1007/s00198-005-1986-1
-
Barrera BA, Wilton L, Harris S, Shakir SA (2005) Prescriptionevent monitoring study on 13,164 patients prescribed risedronate in primary care in England. Osteoporos Int 16(12):1989-1998 (Pubitemid 41790918)
-
(2005)
Osteoporosis International
, vol.16
, Issue.12
, pp. 1989-1998
-
-
Barrera, B.A.1
Wilton, L.2
Harris, S.3
Shakir, S.A.W.4
-
9
-
-
78049428909
-
Ocular side effects of bisphosphonates: A case report and literature review
-
McKague M, Jorgenson D, Buxton KA (2010) Ocular side effects of bisphosphonates: a case report and literature review. Can Fam Physician 56(10):1015-1017
-
(2010)
Can Fam Physician
, vol.56
, Issue.10
, pp. 1015-1017
-
-
McKague, M.1
Jorgenson, D.2
Buxton, K.A.3
-
10
-
-
45749133481
-
Nodular scleritis following alendronate therapy
-
DOI 10.1080/09273940802056281, PII 793260742
-
Tabbara KF (2008) Nodular scleritis following alendronate therapy. Ocul Immunol Inflamm 16(3):99-101 (Pubitemid 351874122)
-
(2008)
Ocular Immunology and Inflammation
, vol.16
, Issue.3
, pp. 99-101
-
-
Tabbara, K.F.1
-
11
-
-
68849121140
-
Anterior uveitis complicating zoledronic acid infusion
-
Colucci A, Modorati G, Miserocchi E, Di Matteo F, Rama P (2009) Anterior uveitis complicating zoledronic acid infusion. Ocul Immunol Inflamm 17(4):267-268
-
(2009)
Ocul Immunol Inflamm
, vol.17
, Issue.4
, pp. 267-268
-
-
Colucci, A.1
Modorati, G.2
Miserocchi, E.3
Di Matteo, F.4
Rama, P.5
-
12
-
-
23044479731
-
Bisphosphonate-associated scleritis: A case report and review
-
DOI 10.1097/01.SMJ.0000152753.80490.9F
-
Leung S, Ashar BH, Miller RG (2005) Bisphosphonate-associated scleritis: a case report and review. South Med J 98(7):733-735, Review (Pubitemid 41061662)
-
(2005)
Southern Medical Journal
, vol.98
, Issue.7
, pp. 733-735
-
-
Leung, S.1
Ashar, B.H.2
Miller, R.G.3
-
13
-
-
37849033010
-
Risedronate induced transient ocular myasthenia
-
Raja V, Sandanshiv P, Neugebauer M (2007) Risedronate induced transient ocular myasthenia. J Postgrad Med 53(4):274-275
-
(2007)
J Postgrad Med
, vol.53
, Issue.4
, pp. 274-275
-
-
Raja, V.1
Sandanshiv, P.2
Neugebauer, M.3
-
14
-
-
36749097425
-
Bilateral severe fibrinous anterior uveitis - An unusual complication of pamidronate therapy exacerbated by topical latanoprost
-
DOI 10.1089/jop.2007.0046
-
Ramasamy B, Quah S, Sahni JN, Palimar P (2007) Bilateral severe fibrinous anterior uveitis - an unusual complication of pamidronate therapy exacerbated by topical latanoprost. J Ocul Pharmacol Ther 23(5):513-515 (Pubitemid 350202484)
-
(2007)
Journal of Ocular Pharmacology and Therapeutics
, vol.23
, Issue.5
, pp. 513-515
-
-
Ramasamy, B.1
Quah, S.2
Sahni, J.N.3
Palimar, P.4
-
15
-
-
0030037880
-
Iritis following intravenous pamidronate
-
Stewart GO, Stuckey BG, Ward LC, Prince RL, Gutteridge DH, Constable IJ (1996) Iritis following intravenous pamidronate. Aust N Z J Med 26(3):414-415 (Pubitemid 26244671)
-
(1996)
Australian and New Zealand Journal of Medicine
, vol.26
, Issue.3
, pp. 414-415
-
-
Stewart, G.O.1
Stuckey, B.G.A.2
Ward, L.C.3
Prince, R.L.4
Gutteridge, D.H.5
Constable, I.J.6
|